Immunological Properties of Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells

Publication date: Available online 16 August 2018Source: Stem Cell ReportsAuthor(s): Masha Idelson, Ruslana Alper, Alexey Obolensky, Nurit Yachimovich-Cohen, Jacob Rachmilewitz, Ayala Ejzenberg, Ekaterina Beider, Eyal Banin, Benjamin ReubinoffSummaryAge-related macular degeneration is caused by dysfunction and loss of retinal pigment epithelium (RPE) cells, and their transplantation may rescue visual functions and delay disease progression. Human embryonic stem cells (hESCs) may be an unlimited source of RPE cells for allotransplantation. We analyzed the immunomodulatory properties of hESC-derived RPE (hESC-RPE) cells, and showed that they inhibited T cell responses. Co-culture experiments showed that RPE cells inhibited interfon-γ secretion and proliferation of activated T cells. Furthermore, hESC-RPE cells enhanced T cell apoptosis and secretion of the anti-inflammatory cytokine interleukin-10 (IL-10). In addition, RPE cells altered the expression of T cell activation markers, CD69 and CD25. RPE cells transplanted into RCS rats without immunosuppression survived, provided retinal rescue, and enhanced IL-10 blood levels. Our data suggest that hESC-RPE cells have immunosuppressive properties. Further studies will determine if these properties are sufficient to alleviate the need for immunosuppression therapy after their clinical allotransplantation.
Source: Stem Cell Reports - Category: Stem Cells Source Type: research